- cafead May 01, 2024 at 11:12: AM
via Eli Lilly’s explosion into the weight loss space is proving fruitful for shareholders, but it’s also providing fresh opportunities for biotechs looking for a Big Pharma partnership.
Lilly’s incubator arm, Gateway Labs, already operates two sites in South Francisco. The organization is set to expand to the east coast in August via a presence at the Lilly Institute for Genetic Medicine in Boston's Seaport district. That will be followed by another opening later this year in San Diego.
article source
Lilly’s incubator arm, Gateway Labs, already operates two sites in South Francisco. The organization is set to expand to the east coast in August via a presence at the Lilly Institute for Genetic Medicine in Boston's Seaport district. That will be followed by another opening later this year in San Diego.
article source